Terumo (OTCMKTS:TRUMY) Stock Price Down 4.8% - Time to Sell?

Key Points

• Terumo Corp.'s stock price dropped 4.8% to $17.81, with trading volume down significantly to 3,925 shares compared to an average of 158,856 shares.
• The company's most recent quarterly earnings showed an EPS of $0.20, exceeding estimates, but revenue came in lower than expected at $1.76 billion against a $1.80 billion forecast.
• Terumo has a market capitalization of $26.32 billion and operates in multiple segments including Cardiac and Vascular products, indicating a diverse range within the healthcare sector.

Shares of Terumo Corp. (OTCMKTS:TRUMY - Get Free Report) were down 4.8% during mid-day trading on Monday . The stock traded as low as $17.81 and last traded at $17.81. Approximately 3,925 shares changed hands during trading, a decline of 98% from the average daily volume of 158,856 shares. The stock had previously closed at $18.71.

Terumo Stock Performance

The stock has a market capitalization of $26.61 billion, a P/E ratio of 31.53 and a beta of 0.80. The stock has a 50 day moving average of $17.63 and a 200 day moving average of $18.21. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.78 and a current ratio of 2.64.

Terumo (OTCMKTS:TRUMY - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.20 EPS for the quarter, topping analysts' consensus estimates of $0.17 by $0.03. Terumo had a return on equity of 9.19% and a net margin of 12.09%.The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.80 billion.

Terumo Company Profile

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.